Corporate and Group information (Tables)

12 Months Ended

Dec. 31, 2025

Disclosure Of Corporate And Group Information [Abstract]

Summary of Subsidiaries

The consolidated financial statements of the Group include:

			% of equity interest
Name	Legal seat	Country of incorporation	2025			2024
Pharvaris Holdings B.V.	Leiden	The Netherlands		100	%		100	%
Pharvaris Netherlands B.V.	Leiden	The Netherlands		100	%		100	%
Pharvaris, Inc.	Delaware	United States of America		100	%		100	%
Pharvaris GmbH	Zug	Switzerland		100	%		100	%
Pharvaris Pharmaceuticals, Inc.*	Delaware	United States of America		100	%	N/A

*Pharvaris Pharmaceuticals, Inc was incorporated in June 2025